Back to COGTView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Advanced Gastrointestinal Stromal Tumors
View Full LandscapeDrug Information
Target Indication
Advanced Gastrointestinal Stromal Tumors
Clinical Trial
NCT05208047Last updated: 12/4/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
CGT9486Phase 3
Gastrointestinal Stromal Tumors
bezuclastinibPhase 2
Advanced Systemic Mastocytosis (AdvSM)
Bezuclastinib Tablets (Formulation A)Phase 2
SSM
CGT4859Phase 2
Intrahepatic Cholangiocarcinoma (Icc)
Bezuclastinib in combination with sunitinibPhase 2
Gastrointestinal Stromal Tumors
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts